Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and spinal cord of the central nervous system (CNS).

Humans have long dreamed of a cure-all.Subscribe to The Post Most newsletter for the most important and interesting stories ...

A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...

Timely resolution of inflammation induced by standard-of-care cancer treatments can be a common approach to prevent ...

FDA grants Orphan Drug Designation to SignaBlok's first-in-class, new mechanism-based TREM-1 peptide inhibitor to treat ...

Skin conditions such as psoriasis often flare up in the same spots throughout one’s life. Now scientists think they know why ...

One of the most puzzling aspects of common chronic inflammatory skin diseases such as psoriasis is how they become chronic.

Sex differences in the prevalence, severity, and disability associated with pain are well documented in both clinical and preclinical research. Despite ...

Goldman Sachs 9th Annual Biopharma Innovation Summit March 26, 2026 5:00 AM EDTCompany ParticipantsKaivan Khavandi - Senior VP, Global Head ...

Richard DiPaolo, PhD, and Jonathan Kay, MD, FACP, MACR. Cue Biopharma management and KOLs will discuss CUE-401, the companys ...